OBX 10-Q: SEC filing
Obsidian Therapeutics
Filed with the SEC on · accession 0001193125-26-458414
OBX filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -3.1% by the first close after the filing.
Summary of the filing
Obsidian Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results including research and development and general and administrative expenses, stock-based compensation, and equity plan activity following its merger with Legacy Obsidian.
Key details
How OBX stock reacted
Close before
$12.88
Nov 11, 2026
First close after
-3.11%
$12.48
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for OBX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for OBX?
Click hereFrequently asked questions
What did OBX file with the SEC on Nov 12, 2026?
OBX filed a 10-Q (SEC filing). Obsidian Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results including research and development and general and administrative expenses, stock-based compensation, and equity plan activity following its merger with Legacy Obsidian.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did OBX stock react to this filing?
OBX closed at $12.88 before the filing and $12.48 on Nov 12, 2026 (-3.11%).
Other OBX SEC filings
Get alerts when OBX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days